Skip to main content
Top
Published in: Annals of Hematology 12/2006

01-12-2006 | Letter to the Editor

Is β-thalassemia trait a risk factor for developing depression in young adults?

Authors: Vahid Emad Marvasti, Pooya Dastoori, Mehran Karimi

Published in: Annals of Hematology | Issue 12/2006

Login to get access

Excerpt

Dear editor, …
Literature
1.
go back to reference Azar Kavian A (2004) Treatment program of major â thalassemia patients in Iran, 3rd ME Thalassemia investigators and thought leaders meeting, Jordan—abstract book Azar Kavian A (2004) Treatment program of major â thalassemia patients in Iran, 3rd ME Thalassemia investigators and thought leaders meeting, Jordan—abstract book
2.
go back to reference Karimi M, Ghavanini A, Kadivar MR (2000) Regional mapping of the gene frequency of β-thalassemia in Fars province, Iran during 1997–1998. Iran J Med Sci 25(3&4):134–137 Karimi M, Ghavanini A, Kadivar MR (2000) Regional mapping of the gene frequency of β-thalassemia in Fars province, Iran during 1997–1998. Iran J Med Sci 25(3&4):134–137
3.
go back to reference Maioli M, Pettinato S, Cherchi GM et al (1989) Plasma lipids in beta-thalassemia minor. Atherosclerosis 75(2–3):245–248 (Feb)PubMedCrossRef Maioli M, Pettinato S, Cherchi GM et al (1989) Plasma lipids in beta-thalassemia minor. Atherosclerosis 75(2–3):245–248 (Feb)PubMedCrossRef
4.
go back to reference Partonen T, Haukka J, Virtamo J et al (1999) Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry 175:259–262 (Sep)PubMedCrossRef Partonen T, Haukka J, Virtamo J et al (1999) Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry 175:259–262 (Sep)PubMedCrossRef
5.
go back to reference Hawton K, Cowen P, Owens D (1993) Low serum cholesterol and suicide. Br J Psychiatry 162:818–825 Hawton K, Cowen P, Owens D (1993) Low serum cholesterol and suicide. Br J Psychiatry 162:818–825
6.
go back to reference Zureik M, Courbon D, Ducimetiere P (1996) Serum cholesterol concentration and death from suicide in men: Paris prospective study I. BMJ 313:649–651PubMed Zureik M, Courbon D, Ducimetiere P (1996) Serum cholesterol concentration and death from suicide in men: Paris prospective study I. BMJ 313:649–651PubMed
7.
go back to reference Law M, Thompson S, Wald N (1994) Assessing possible hazards of reducing serum cholesterol. BMJ 308:373–379PubMed Law M, Thompson S, Wald N (1994) Assessing possible hazards of reducing serum cholesterol. BMJ 308:373–379PubMed
8.
go back to reference Muldoon MF, Manuck SB, Matthews K (1990) Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trails. BMJ 301:309–314PubMedCrossRef Muldoon MF, Manuck SB, Matthews K (1990) Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trails. BMJ 301:309–314PubMedCrossRef
9.
go back to reference Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMed Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMed
10.
Metadata
Title
Is β-thalassemia trait a risk factor for developing depression in young adults?
Authors
Vahid Emad Marvasti
Pooya Dastoori
Mehran Karimi
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 12/2006
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-006-0154-9

Other articles of this Issue 12/2006

Annals of Hematology 12/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine